Abstract |
Cardiopulmonary complications are major drivers of mortality caused by the SARS-CoV-2 virus. Interleukin-18, an inflammasome-induced cytokine, has emerged as a novel mediator of cardiopulmonary pathologies but its regulation via SARS-CoV-2 signaling remains unknown. Based on a screening panel, IL-18 was identified amongst 19 cytokines to stratify mortality and hospitalization burden in patients hospitalized with COVID-19. Supporting clinical data, administration of SARS-CoV-2 Spike 1 (S1) glycoprotein or receptor-binding domain (RBD) proteins into human angiotensin-converting enzyme 2 (hACE2) transgenic mice induced cardiac fibrosis and dysfunction associated with higher NF-κB phosphorylation (pNF-κB) and cardiopulmonary-derived IL-18 and NLRP3 expression. IL-18 inhibition via IL-18BP resulted in decreased cardiac pNF-κB and improved cardiac fibrosis and dysfunction in S1- or RBD-exposed hACE2 mice. Through in vivo and in vitro work, both S1 and RBD proteins induced NLRP3 inflammasome and IL-18 expression by inhibiting mitophagy and increasing mitochondrial reactive oxygenation species. Enhancing mitophagy prevented Spike protein-mediated IL-18 expression. Moreover, IL-18 inhibition reduced Spike protein-mediated pNF-κB and EC permeability. Overall, the link between reduced mitophagy and inflammasome activation represents a novel mechanism during COVID-19 pathogenesis and suggests IL-18 and mitophagy as potential therapeutic targets.
|
Authors | Shuxin Liang, Changlei Bao, Zi Yang, Shiyun Liu, Yanan Sun, Weitao Cao, Ting Wang, Tae-Hwi Schwantes-An, John S Choy, Samisubbu Naidu, Ang Luo, Wenguang Yin, Stephen M Black, Jian Wang, Pixin Ran, Ankit A Desai, Haiyang Tang |
Journal | Signal transduction and targeted therapy
(Signal Transduct Target Ther)
Vol. 8
Issue 1
Pg. 108
(03 09 2023)
ISSN: 2059-3635 [Electronic] England |
PMID | 36894537
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural)
|
Copyright | © 2023. The Author(s). |
Chemical References |
- spike protein, SARS-CoV-2
- Spike Glycoprotein, Coronavirus
- Inflammasomes
- Interleukin-18
- NLR Family, Pyrin Domain-Containing 3 Protein
- Cytokines
|
Topics |
- Humans
- Mice
- Animals
- Spike Glycoprotein, Coronavirus
(metabolism)
- SARS-CoV-2
(metabolism)
- COVID-19
(genetics)
- Inflammasomes
(genetics, metabolism)
- Interleukin-18
(genetics)
- NLR Family, Pyrin Domain-Containing 3 Protein
(genetics, metabolism)
- Mitophagy
(genetics)
- Inflammation
(genetics, metabolism)
- Cytokines
|